U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230145) titled 'A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure' on Nov. 13.
Brief Summary: This is a clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamic and immunogenicity of single subcutaneous injection of SHR-4658 in healthy volunteers and volunteers with elevated blood pressure.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Heart Failure
Intervention:
DRUG: SHR-4658 Injection.
SHR-4658 injection.
DRUG: SHR-4658 Placebo Injection
SHR-4658 placebo injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Beijing Suncadia Pharmaceuticals Co., ...